Los Angeles, United States
Digitalis is devoted to supporting cutting-edge concepts in mathematics and science that have the potential to tackle intricate health issues, making it a venture capital corporation.
58
Total Investments
38
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biopharma, Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Digitalis Ventures
Recent Investments (58)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jan 2026 | |
| Series A | •••••• | Oct 2024 | |
| Series B | •••••• | Oct 2024 | |
| Series B | •••••• | Jul 2024 | |
| Series B | •••••• | Jul 2024 | |
•••• ••••
|
Series B | •••••• | May 2024 |
|
•••• ••••
|
Series B | •••••• | May 2024 |
|
•••• ••••
|
Series B | •••••• | Apr 2024 |
|
•••• ••••
|
Series A | •••••• | Mar 2024 |
|
•••• ••••
|
Series A - T | •••••• | Nov 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
